{"transactions":[{"id":1314818,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2025-01-03T16:05:16.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan."}],"balance_after":80000,"derivative":{"exercise_price":0.5995,"expiration_date":"2034-12-30","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-25-000235","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315225000235/ownership.xml","form_type":"4"}},{"id":1720113,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-06T16:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the option vested on December 29, 2021 (the \" 2021 Date of Grant\"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":20.2,"expiration_date":"2031-12-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-23-043893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315223043893/ownership.xml","form_type":"4"}},{"id":1720112,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-06T16:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"20% of the option vested on December 22, 2020 (the \"2020 Date of Grant\"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":16.8,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-23-043893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315223043893/ownership.xml","form_type":"4"}},{"id":1720111,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-06T16:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations"}],"balance_after":0,"derivative":{"exercise_price":14.1,"exercise_date":"2020-10-01","expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001493152-23-043893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315223043893/ownership.xml","form_type":"4"}},{"id":1720110,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-06T16:45:11.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":8.94,"expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001493152-23-043893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315223043893/ownership.xml","form_type":"4"}},{"id":1720109,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-06T16:45:11.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":20000,"derivative":{"exercise_price":1.24,"expiration_date":"2023-11-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-23-043893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315223043893/ownership.xml","form_type":"4"}},{"id":2454321,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-01-03T13:47:58.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal installments on each three-month anniversary of the grant date (December 29, 2021), in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":300000,"derivative":{"exercise_price":1.01,"expiration_date":"2031-12-28","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-22-000078","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315222000078/ownership.xml","form_type":"4"}},{"id":2933055,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2020-12-23T18:50:57.000Z","date":"2020-12-22","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"20% of the option vested on December 22, 2020 (the \"Date of Grant\"), with an additional 20% to vest on the three month anniversary of the Date of Grant, a further 20% to vest on the six month anniversary of the Date of Grant, a further 20% to vest on the nine month anniversary of the Date of Grant, and the final 20% to vest on the year anniversary of the Date of Grant."}],"balance_after":200000,"derivative":{"exercise_price":0.84,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-20-024276","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315220024276/ownership.xml","form_type":"4"}},{"id":2992873,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2020-11-04T17:56:52.000Z","date":"2020-11-02","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":4.75,"expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-20-020493","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315220020493/ownership.xml","form_type":"4"}},{"id":2992872,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2020-11-04T17:56:52.000Z","date":"2020-11-02","kind":"disposition_to_issuer","acquired":false,"shares":183359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 14, 2016, the reporting person was granted an option to purchase shares of common stock outside the NanoVibronix, Inc. 2014 Long-Term Incentive Plan. The option vested or vests, as applicable, in four installments as follows: (i) 1/4 of the total shares (rounded down for fractional shares) on the first anniversary of the grant date, (ii) 1/4 of the total shares (rounded down for fractional shares) on the second anniversary of the grant date, (iii) 1/4 of the total shares (rounded down for fractional shares) on the third anniversary of the grant date, and (iv) the remaining shares on the fourth anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2026-11-14","underlying":"Common Stock","underlying_shares":183359},"source":{"system":"sec-edgar","filing":"0001493152-20-020493","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315220020493/ownership.xml","form_type":"4"}},{"id":3013388,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2020-10-05T19:50:53.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested on October 1, 2020."}],"balance_after":50000,"derivative":{"exercise_price":0.72,"expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-018961","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000149315220018961/ownership.xml","form_type":"4"}},{"id":3841925,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2018-08-16T16:33:03.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019. Vesting is subject to the reporting person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The option vests in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019. Vesting is subject to the reporting person's continued service to the Issuer."}],"balance_after":75000,"derivative":{"exercise_price":4.75,"expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001615774-18-008225","document":"s112125_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000161577418008225/s112125_form4.xml","form_type":"4"}},{"id":4553048,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84513,"kind":"person","name":"Murphy Brian M","position":1,"cik":"0001687795","reported_name":"Murphy Brian M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2016-11-16T16:12:31.000Z","date":"2016-11-14","kind":"grant","acquired":true,"shares":183359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 14, 2016, the reporting person was granted an option to purchase shares of common stock outside the NanoVibronix, Inc. 2014 Long-Term Incentive Plan. The option vests in four installments as follows: (i) 1/4 of the total shares (rounded down for fractional shares) on the first anniversary of the grant date, (ii) 1/4 of the total shares (rounded down for fractional shares) on the second anniversary of the grant date, (iii) 1/4 of the total shares (rounded down for fractional shares) on the third anniversary of the grant date, and (iv) the remaining shares on the fourth anniversary of the grant date. Vesting is subject to the reporting person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 14, 2016, the reporting person was granted an option to purchase shares of common stock outside the NanoVibronix, Inc. 2014 Long-Term Incentive Plan. The option vests in four installments as follows: (i) 1/4 of the total shares (rounded down for fractional shares) on the first anniversary of the grant date, (ii) 1/4 of the total shares (rounded down for fractional shares) on the second anniversary of the grant date, (iii) 1/4 of the total shares (rounded down for fractional shares) on the third anniversary of the grant date, and (iv) the remaining shares on the fourth anniversary of the grant date. Vesting is subject to the reporting person's continued service to the Issuer."}],"balance_after":183359,"derivative":{"exercise_price":6,"expiration_date":"2026-11-14","underlying":"Common Stock","underlying_shares":183359},"source":{"system":"sec-edgar","filing":"0001144204-16-134957","document":"v453304_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1687795/000114420416134957/v453304_4.xml","form_type":"4"}}]}